Botanical species · safety record

Hemerocallis fulva

The EFSA Compendium of Botanicals holds 10 constituent measurements for Hemerocallis fulva. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hemerocallis fulva (L.) L.

10Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Also recorded as

Hemerocallis fulva var. kwanso Regel
Hemerocallis lilioasphodelus L.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Flower	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Anthraquinones	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Steroidal saponins	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Stem / stalk	—	—	—	No resolvable identifier
Alkaloids	Roots and other underground parts	—	—	—	No resolvable identifier
Anthraquinones	Roots and other underground parts	Solvent extraction	≥ 0.019 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Anthraquinones	Roots and other underground parts	Solvent extraction	≤ 0.32 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Hemerocallin	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Isoflavones	Roots and other underground parts	—	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Saponins	Roots and other underground parts	—	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Wang, Qiang., Yang, Jingxion. Determination of anthraquinones and chrysophanol in radix hemerocallis. Zhongcaoyao, 1990, p. 12-13.
Yang, Zhong-Duo L., Li, Tao., Li, Yuan-Chao. Chemical constituents in root of Hemerocallis fulva .. Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2008, vol. 33, no. 3, p. 269-72.
Konishi, T., Fujiwara, Y., Konoshima, T., Kiyosawa, S., Nishi, M., Miyahara, K. Steroidal saponins from Hemerocallis fulva var. kwanso. CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, vol. 49, no. 3, p. 318-320. DOI
Cichewicz, RH., Zhang, YJ., Seeram, NP., Nair, MG. Inhibition of human tumor cell proliferation by novel anthraquinones from daylilies. LIFE SCIENCES, 2004, vol. 74, no. 14, p. 1791-1799. DOI
Liu, Yan-ze., Wu, Jie., Zhu, Yu., Du, Chen-xia., Chang, Jun-biao., Xie, Jing-xi. Preparation and crystal structure of acetyl hemerocallin and structural revision of hemerocallin. Chinese Herbal Medicines, 2013, p. 158-162.
Crum, J. D., Cassady, J. M., Olmstead, P. M., Picha, N. J. The chemistry of alkaloids. I. The screening of some native Ohio plants. Proc. west va. acad. sci., 1965, p. 143-147.
Matsumoto, Takahiro., Nakamura, Seikou., Ohta, Tomoe., Fujimoto, Katsuyoshi., Yoshikawa, Masayuki., Ogawa, Keiko., Matsuda, Hisashi. A Rare Glutamine Derivative from the Flower Buds of Daylily. ORGANIC LETTERS, 2014, vol. 16, no. 11, p. 3076-3078. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature